Board Appointment & Grant of share options
Updated : 11:43
Swallowfield plc
("Swallowfield" or "the Company")
Board Appointment
& Grant of share options
Swallowfield plc, a market leader in the development, formulation, and supply of personal care and beauty products, including its own portfolio of brands refers to its announcement on 27 February 2018 and confirms that Tim Perman will be appointed to the board of Swallowfield as Chief Executive Officer with effect from 1 July 2018. As announced at that time, Tim will replace Chris How who will step down from the board on 1 July 2018.
Pursuant to the rules of the Swallowfield plc 2009 Long Term Incentive Plan ("LTIP"), the Company has granted options to certain directors and employees to subscribe for up to 212,190 ordinary shares of 5p each (the "Options") as follows:
Director/Employee | Number of new Options granted | Total Number of Options now held | % of issued share capital represented by Options now held |
Tim Perman | 77,160 | 77,160 | 0.45% |
Jane Fletcher | 77,160 | 99,877 | 0.58% |
Matthew Gazzard | 57,870 | 57,870 | 0.34% |
212,190 234,907 1.37%
All of the 212,190 new Options granted under the LTIP have performance conditions attached to them linked to earning per share targets. The award for Jane Fletcher represents a 24-month period and for Matthew Gazzard an 18-month period in the absence of an award being made to those individuals for the trading year 2018. In relation to Tim Perman the award represents a 12-month period. To the extent that the performance conditions are met at the end of the three-year performance cycle, then the Options can be exercised at a price of £0.05 per Option. They are exercisable, to the extent vested and subject to meeting the performance criteria, for a period of 10 years from the date of grant.
Following the grant of the Options the total number of ordinary shares subject to options and which could, in the future, be issued is 535,000. This represents 3.12% of the current issued share capital of the Company which comprises 17,135,542 Ordinary Shares.
For further information, please contact: |
| |
Swallowfield plc |
|
|
Chris How | Chief Executive Officer | 01823 662 241 |
Matthew Gazzard | Group Finance Director | 01823 662 241 |
|
|
|
Mark Taylor/ Jen Boorer | N+1 Singer | 0207 496 3000 |
Josh Royston / Hilary Buchanan | Alma PR | 07780 901979 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Tim Perman | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| CEO Designate | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Swallowfield plc | ||||
b)
| LEI
| 213800BSD8D9QEUKCE17 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 5 pence each
GB0008667304 | ||||
b)
| Nature of the transaction
| Grant of options | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
| N/A | ||||
e)
| Date of the transaction
| 18th June 2018 | ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
c
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Jane Fletcher | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Group Sales And Marketing Director | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Swallowfield plc | ||||
b)
| LEI
| 213800BSD8D9QEUKCE17 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 5 pence each
GB0008667304 | ||||
b)
| Nature of the transaction
| Grant of options | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
| N/A | ||||
e)
| Date of the transaction
| 18th June 2018 | ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Matthew Gazzard | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Group Finance Director | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Swallowfield plc | ||||
b)
| LEI
| 213800BSD8D9QEUKCE17 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 5 pence each
GB0008667304 | ||||
b)
| Nature of the transaction
| Grant of options | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
| N/A | ||||
e)
| Date of the transaction
| 18th June 2018 | ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.